 CAMBRIDGE, Mass., Nov. 11, 2022 GLOBE NEWSWIRE -- Cerevel Therapeutics, Nasdaq: CERE, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that members of the management team will participate in three upcoming investor conferences. 